Cite
HARVARD Citation
Knox, J. et al. (2018). Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. Annals of oncology. p. 2269. [Online].